An HIV/AIDS Vaccine
Consortium for HIV/AIDS Vaccine Development
This project aims to create a vaccine that can protect people from HIV infection by teaching the body to make strong protective antibodies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Scripps Research Institute, the NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-11141060 on NIH RePORTER |
What this research studies
Researchers are working to develop a new vaccine for HIV that helps your body produce special antibodies, called broadly neutralizing antibodies (bnAbs), which can fight off many different types of the virus. They believe an effective vaccine will need to trigger these bnAbs against several parts of the HIV virus in most people who receive it. The team is using a step-by-step approach, testing different vaccine components to guide the body's immune response. They are also exploring other types of antibodies that could help clear infected cells or work with bnAbs for even better protection. This work has shown promising results in early laboratory and animal tests, with some vaccine components already moving towards human testing.
Who could benefit from this research
Good fit: Ideal candidates for future vaccine trials would be individuals at risk of HIV infection or those interested in contributing to preventative medicine.
Not a fit: Patients already living with HIV would not directly benefit from this preventative vaccine, though advancements in understanding the virus could indirectly help.
Why it matters
Potential benefit: If successful, this vaccine could offer complete protection against HIV infection, preventing the spread of the virus and saving lives.
How similar studies have performed: This sequential vaccine strategy has shown proof-of-principle in preclinical models, and some vaccine components are already progressing to clinical trials, indicating early success and a novel approach.
Where this research is happening
La Jolla, United States
- Scripps Research Institute, the — La Jolla, United States (Active)
Researchers
- Principal investigator: Burton, Dennis R. — Scripps Research Institute, the
- Study coordinator: Burton, Dennis R.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.